TOKYO – Taiho Pharmaceutical Co. Ltd. has formed a new venture in the U.S. backed with $50 million to search for oncology start-ups in which to invest. Taiho Ventures said it will look for companies that "discover and develop innovative therapeutic products and/or drug-enabling platform technologies that demonstrate a clear potential to benefit cancer patients."